MONDAY, NOVEMBER 20, 2017

American Society for Microbiology

1752 N St NW
Washington, DC - 20036

American Society for Microbiology News

Real-time system monitors Ebola through a microscope

Scientists recently published an article in mBio, a journal from the American Society for Microbiology, that suggests the first real-time system can monitor Ebola through a microscope while the Ebola-like virus particles infect and bond with human cells. Read More »

Study challenges strategy for developing vaccine for MERS-CoV

A recent Seoul National University College of Medicine study shows that the current strategy for developing a vaccine for the Middle East Respiratory Syndrome coronavirus (MERS-CoV) needs to be improved, as the virus mutates during an outbreak so that it becomes less virulent. Read More »

Multi-tasking flu vaccine may offer improved protection

Australian researchers recently discovered a method of improving the efficacy and cross-protective abilities of a vaccine for influenza A by adding one component. Read More »

Study finds HIV particles trapped more effectively by certain cervicovaginal mucus

Findings of a recent study indicating that HIV particles are more effectively trapped by the cervicovaginal mucus (CVM) in women who harbor the vaginal bacteria species Lactobacillus crispatus were published Tuesday in mBio, the open access journal of the American Society for Microbiology (ASM).  Read More »

Children with cerebral malaria show novel disease signatures

Researchers recently discovered that children who have cerebral malaria have novel signatures of the disease in their brains. Read More »

Women-only HIV study improves understanding of effective, safe antiretroviral treatments

Researchers recently presented the results from the first phase 3 HIV study that recruited only women to demonstrate the improved efficacy and safety of Stribild compared to multi-pill antiretroviral drug regimens. Read More »

Study shows influenza vaccines offer moderate protection during flu season

A recent study shows that people who accepted the influenza vaccine had moderate protection against the flu for the duration of the entire flu season, up to six months, the American Society for Microbiology said Tuesday. Read More »

Intranasal virus-like particle vaccine shown to be effective against influenza A virus

A study published Tuesday in mBios, the American Society for Microbiology (ASM) journal, has found that an intranasal virus-like particle (VLP) vaccine offers broad protection to mice against several subtypes of influenza A virus. Read More »

Generic heart disease medications may treat Ebola

Researchers recently found that generic medications that are used to manage heart disease patients may also significantly strengthen patients’ immune systems against Ebola and similar life-threatening diseases. Read More »

New drug shows early promise as Ebola vaccine

Researchers recently administered an experimental drug that targets an Ebola virus protein to a group of monkeys and discovered that 75 percent of the monkeys did not contract the virus after virus exposure. Read More »